Cargando…
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial
BACKGROUND: There is a large population of restless legs syndrome (RLS) patients who are refractory to medication. Whereas experts recommend off-label opioids as an effective long-term treatment for refractory RLS, reducing opioid dose could substantially reduce side effects and risks. Tonic motor a...
Autores principales: | Buchfuhrer, Mark J., Roy, Asim, Rodriguez, Stephanye, Charlesworth, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662398/ https://www.ncbi.nlm.nih.gov/pubmed/37990163 http://dx.doi.org/10.1186/s12883-023-03462-6 |
Ejemplares similares
-
Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial
por: Bogan, Richard K, et al.
Publicado: (2023) -
Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
por: Roy, Asim, et al.
Publicado: (2023) -
Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory Analysis
por: Ryschon, Anne M., et al.
Publicado: (2023) -
Restless Legs Syndrome and Leg Motor Restlessness in Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2015) -
Restless Legs Syndrome in Opioid Dependent Patients
por: Ghosh, Abhishek, et al.
Publicado: (2014)